John Rogers, MD
Adult Medicine · The Woodlands, TXNPI 1194828020
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,074 and has fallen 98.7% since, to $14 in 2025.
Across 92 payments — averaging $24.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$466
- Amgen$435
- AbbVie$349
- Novo Nordisk$220
- Idorsia Pharmaceuticals US Inc$159
- Inspire Medical Systems, Inc.$125
- plus $512 from 14 others
What the payments were for
- Food & beverage$2,266100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 16 | $466 |
| Amgen(2 entities) | 13 | $435 |
| AbbVie(2 entities) | 14 | $349 |
| Novo Nordisk | 15 | $220 |
| Idorsia Pharmaceuticals US Inc | 3 | $159 |
| Inspire Medical Systems, Inc. | 1 | $125 |
| Merck | 5 | $75 |
| Daiichi Sankyo Inc. | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Eisai Inc. | 3 | $53 |
| AstraZeneca | 3 | $52 |
| Lilly USA, LLC | 3 | $45 |
| GSK | 2 | $31 |
| Novartis | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $28 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Pfizer | 1 | $15 |
| Abbott | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,266 in reported general payments places this provider in the 75th percentile of 98 adult medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 17 | $12,355 |
| SynthroidLevothyroxine Sodium | 14 | $1,279 |
| Rosuvastatin Calcium | 48 | $1,206 |
| Testosterone Cypionate | 11 | $1,068 |
| Estradiol (Twice Weekly)Estradiol | 12 | $1,062 |
| Lidocaine | 11 | $802 |
| Ezetimibe | 15 | $483 |
| Bupropion XlBupropion Hcl | 12 | $428 |
| Atorvastatin Calcium | 21 | $423 |
| Gabapentin | 23 | $419 |
| Nifedipine ErNifedipine | 18 | $390 |
| Duloxetine Hcl | 29 | $342 |
| Lisinopril | 27 | $326 |
| Liothyronine Sodium | 11 | $284 |
| ProgesteroneProgesterone, Micronized | 13 | $279 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $349 | $1,27914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 98 adult medicine providers in Texas.
Other adult medicine in The Woodlands
- Deborah HornBellaire$723K
- Thomas MartensPflugerville$87K
- Sakuntalai SrinanthakumarBeaumont$48K
- Francisco Vera AdamesSpring$11K
- Latisha RoweHouston$11K
- Hong XiaoCarrollton$10K
- Mark NovasSheppard Afb$9K
- Daisy ArceWeslaco$9K
- Jeffory ThomasTexarkana$8K
- Manuel SanchezMcAllen$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.